Stay Ahead: Insights from APCO

APCO’s Reset Indicator: Comparing Public Attitudes Toward COVID-19 Around the World

APCO is tracking attitudes and behaviors related to COVID-19 in a series of polls. The latest installment, from polling conducted October 6-7, 2020, included research from around the world on coronavirus recovery. The APCO Reset Indicator monitors global public attitudes and behaviors as the world responds to the COVID-19 pandemic. The latest study in our series tracks views of Americans and adds perspectives from Great Britain, Germany, Italy, Singapore and India. For more on APCO’s research, follow us on Twitter, and read the full report on our blog

Mask

"According to the APCO Worldwide global poll of 900 adults, most believe they are still amidst the crisis or are soon returning to it. Yet, as individuals, they are generally optimistic about their standings, including mental and physical health, personal finances and privacy, while they are simultaneously expecting more from leadership of their elected officials, and national and global economies. Notably, the public in Asia tend to be more optimistic than those in Europe and the United States. Despite the lingering uncertainties, healthcare providers remain far more likely to be seen as doing the right things in all the markets of our study."

EU Strategic Autonomy and Germany’s Corona Council Presidency

Christoph Mielke, a senior director, and Gregoire Zammit, associate consultant, at APCO Worldwide’s Brussels office discuss how Europe’s ‘strategic autonomy’ has received greater attention over the last months in light of the COVID-19 crisis: 

World map

"The COVID pandemic has been a sharp reminder of the EU’s dependence on third countries to satisfy an essential strategic need: public health. Plagued with issues of shortages, aggressive competition with the US and China over protective equipment and vaccines, the EU has now woken up to the reality of the post-crisis world.

The German-French power couple is expending significant resources on influencing the EU’s expanding role in health. While France seems focused on promoting the reshoring of essential medicines production, the German Presidency is keen on taking a broader approach. The upcoming pharmaceutical strategy, set to be published in December 2020, will be critical in developing strategic autonomy in the field of health.
"

Some Positive News

  • A new soundscape for cities: The reduction in noise pollution brought about by lockdowns and social distancing restrictions has made the sounds of nature more noticeable in cities, Bloomberg
  • Free meals for disadvantaged children: After the UK Parliament voted down a motion to fund free lunches for children over the holiday, communities are working to offer free lunches to families suffering financial hardship due to the pandemic, BBC
  • Dads taking on home responsibilities: Lockdown measures during the pandemic have pushed fathers to dial back their career ambitions and practice full-time parenting, The Wall Street Journal

More Tips from Around the Water Cooler

Quotables


“We will know whether a vaccine is safe and effective by the end of November or the beginning of December. The question is: once you have a safe and effective vaccine, or more than one, how can you get it to the people who need it as quickly as possible? The number of doses that will be available in December will certainly not be enough to vaccinate everyone. We will have to wait several months into 2021 before there are enough to go around. There will be a prioritization set so that individuals such as health workers will be vaccinated first along with those who are at an increased risk of developing complications from the virus.

         -  Anthony S. Fauci, director, U.S. National Institute of Allergy and Infectious Diseases
The APCO team is working with clients globally to manage this crisis, and we stand ready to support your needs. For more resources from APCO, including our latest research, information on how we can help or to contact us, visit apcoworldwide.com/coronavirus.